Our background:

Tiba Oncology is based in Dallas, TX, and is focused exclusively on oncology medical communications. Tiba Oncology is a division of Medical Media Holdings (MMH), a family of companies that includes CIG Media Group, Physicians' Education Resource, and Cure Media Group.

The creation of Tiba Oncology was an effort to leverage the deep oncology expertise and relationships that exist within the MMH family. With a singular focus on non-CME activities and a robust firewall, Tiba Oncology has the capability to provide a full range of strategic products and services to pharmaceutical and biotech companies.

TIBA Oncology, LP (TIBA), a strategic medical communications and marketing research organization, focused exclusively on oncology, is a division of Medical Media Holdings (MMH), a family of companies that includes Cancer Information Group (CIG), Physicians' Education Resource (PER), Cure Media Group (CMG), and Interactive Clinical Intelligence (ICI). As a spin-off of PER and CIG, TIBA was created to leverage the deep oncology expertise and relationships that existed within the MMH family while maintaining the appropriate separation between the other MMH companies.

TIBA staff has retained an extensive network of thought leader relationships gained through interactions with world-class editorial boards of the 7 peer-reviewed and indexed journals published by CIG. Additionally, TIBA staff has extensive oncology experience, deep relationships in many areas of the marketplace, and a high familiarity with key opinion leaders. With a singular focus in oncology, an experienced staff, and a winning attitude, TIBA is an excellent partner to help your company achieve its goals with this important project. We believe projects of this nature are essential to the development, commercialization and maintenance of large oncology brands.